MiMedx to acquire Sanara MedTech for $350M

MiMedx Group will acquire all outstanding shares of Sanara MedTech in a transaction valued at $350 million, combining MiMedx's surgical portfolio with Sanara's technologies in collagen particulate, wound irrigation, and bone fixation.

“The merger would combine MiMedx’s surgical portfolio with Sanara’s technologies in collagen particulate, wound irrigation, and bone fixation.”mpo-mag.com

• 1 source
• mpo-mag.comMiMedx to Buy Sanara MedTech for $350M | Medical Product OutsourcingSam BruscoJul 31, 2026

Summarized from public sources; check the original articles before acting on it.